MedImmune Ventures, Inc., 10% Owner at G1 Therapeutics, Inc. (GTHX), bought 3,484,536 shares at $15.00 ($1.1M) on 2017-05-22, disclosed to the SEC on 2017-05-24.
Open-market purchase of $1.1M GTHX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,409,536 | $0 | 0.0% |
| 2 | $15.00 | 75,000 | $1.1M | 100.0% |
| Total | $0.32 avg | 3,484,536 | $1.1M | 100% |
| Filing → |
| GTHX | SELL | 2017-12-05 | $5.3M | — | Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| CATB | BUY | 2015-06-30 | $2.7M | — | Filing → |